The PDL share price has not improved over time. Maybe the board is thinking that a t/o is the best way forward to get value. The reason that the PDL board said that they rejected PPT was the different cultures of the companies. Maybe money or lack of it is driving a cultural change.
HT1
- Forums
- ASX - By Stock
- Ann: Response to Pendal announcement regarding conditional, non-b
The PDL share price has not improved over time. Maybe the board...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$22.35 |
Change
0.200(0.90%) |
Mkt cap ! $2.550B |
Open | High | Low | Value | Volume |
$22.22 | $22.50 | $22.22 | $6.304M | 281.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1993 | $22.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.42 | 323 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1359 | 22.340 |
2 | 2385 | 22.320 |
1 | 595 | 22.310 |
1 | 756 | 22.290 |
1 | 225 | 22.200 |
Price($) | Vol. | No. |
---|---|---|
22.430 | 546 | 1 |
22.450 | 756 | 1 |
22.460 | 1000 | 1 |
22.480 | 764 | 2 |
22.490 | 500 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PPT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online